Incannex Healthcare Inc IXHL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $3.37
- Day Range
- $3.29–3.48
- 52-Week Range
- $2.49–49.80
- Bid/Ask
- $3.33 / $3.42
- Shares Outstanding
- 11.96M
- Market Cap
- $40.56M
- Volume/Avg
- 143,466 / 347,479
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 12
- Website
- https://www.incannex.com.au
Valuation
|
Metric
|
IXHL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.67 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
IXHL
|
|---|---|
Quick Ratio | 41.47 |
Current Ratio | 41.56 |
Interest Coverage | — |
Quick Ratio
IXHL
Profitability
|
Metric
|
IXHL
|
|---|---|
Return on Assets (Normalized) | −31.46% |
Return on Equity (Normalized) | −34.55% |
Return on Invested Capital (Normalized) | −34.25% |
Return on Assets
IXHL
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|w&R@<sp | LOCK|%z@hK | $69B | |||
| Haleon PLC ADR
HLN
| LOCK|@F$#$m | LOCK|Fz | $43B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|#!Y&&b% | LOCK|$&sXj | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|$?GW!CrH | LOCK|FlX | $32B | |||
| Viatris Inc
VTRS
| LOCK|hfV^Z> | LOCK|??! | $19B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|%?N | LOCK|zSK | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|V#JYF# | LOCK|J$j | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|Y@#%d<J | LOCK|H& | $8B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|y^Q?Z% | LOCK|h#@nS | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|!nf&wvM | LOCK|S& | $1B |
United States